

19 Oct 2022
// Nick Paul Taylor FIERCEPHARMA
https://www.fiercepharma.com/pharma/fda-approves-single-vial-version-gsks-menveo-vaccine-ending-need-reconstitution

18 Oct 2022
// PHARMABIZ

17 Oct 2022
// PRESS RELEASE
https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-menveo-in-a-new-single-vial-presentation-to-help-prevent-disease-caused-by-meningococcal-bacteria-serogroups-a-c-y-and-w/

16 Sep 2022
// Max Bayer FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/pfizer-gears-fda-app-after-ph-3-data-its-pentavalent-meningococcal-vaccine-stand-against

18 Sep 2020
// PHARMATECH
https://www.pharmtech.com/view/ema-recommends-seven-medicines-for-approval